CN106615431A - 一种菊芋片茶及其制作方法 - Google Patents
一种菊芋片茶及其制作方法 Download PDFInfo
- Publication number
- CN106615431A CN106615431A CN201611123265.6A CN201611123265A CN106615431A CN 106615431 A CN106615431 A CN 106615431A CN 201611123265 A CN201611123265 A CN 201611123265A CN 106615431 A CN106615431 A CN 106615431A
- Authority
- CN
- China
- Prior art keywords
- jerusalem artichoke
- sliced
- water
- piece
- helianthus tuberosus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000008892 Helianthus tuberosus Species 0.000 title claims abstract description 217
- 235000003230 Helianthus tuberosus Nutrition 0.000 title claims abstract description 217
- 238000000034 method Methods 0.000 title abstract description 12
- 244000269722 Thea sinensis Species 0.000 title abstract 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 74
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims abstract description 40
- 241000222336 Ganoderma Species 0.000 claims abstract description 38
- 239000012141 concentrate Substances 0.000 claims abstract description 38
- 239000000706 filtrate Substances 0.000 claims abstract description 26
- 238000001035 drying Methods 0.000 claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 22
- 230000006837 decompression Effects 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 241000233866 Fungi Species 0.000 claims abstract description 5
- 240000001307 Myosotis scorpioides Species 0.000 claims abstract description 4
- 241001122767 Theaceae Species 0.000 claims description 75
- 241001264174 Cordyceps militaris Species 0.000 claims description 34
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 16
- 238000007654 immersion Methods 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 230000002829 reductive effect Effects 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 6
- 241000382353 Pupa Species 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- 206010020772 Hypertension Diseases 0.000 abstract description 6
- 229920001202 Inulin Polymers 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 6
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract description 6
- 229940029339 inulin Drugs 0.000 abstract description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract description 5
- 150000004676 glycans Chemical class 0.000 abstract description 4
- 229920001282 polysaccharide Polymers 0.000 abstract description 4
- 239000005017 polysaccharide Substances 0.000 abstract description 4
- 238000010992 reflux Methods 0.000 abstract description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract description 3
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 3
- 239000011669 selenium Substances 0.000 abstract description 3
- 229910052711 selenium Inorganic materials 0.000 abstract description 3
- 239000011573 trace mineral Substances 0.000 abstract description 3
- 235000013619 trace mineral Nutrition 0.000 abstract description 3
- 238000001291 vacuum drying Methods 0.000 abstract description 3
- 235000019155 vitamin A Nutrition 0.000 abstract description 3
- 239000011719 vitamin A Substances 0.000 abstract description 3
- 229940045997 vitamin a Drugs 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 239000001913 cellulose Substances 0.000 abstract description 2
- 229920002678 cellulose Polymers 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 241000267140 Cordyceps taishanensis Species 0.000 abstract 2
- 229930003270 Vitamin B Natural products 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 235000019156 vitamin B Nutrition 0.000 abstract 1
- 239000011720 vitamin B Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 26
- 241000700159 Rattus Species 0.000 description 21
- 238000003304 gavage Methods 0.000 description 17
- 239000000463 material Substances 0.000 description 13
- 229940079593 drug Drugs 0.000 description 10
- 239000004480 active ingredient Substances 0.000 description 8
- 230000036772 blood pressure Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 208000031226 Hyperlipidaemia Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 108010023302 HDL Cholesterol Proteins 0.000 description 5
- 108010028554 LDL Cholesterol Proteins 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 235000021049 nutrient content Nutrition 0.000 description 5
- 238000009461 vacuum packaging Methods 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 201000005577 familial hyperlipidemia Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000007516 Chrysanthemum Nutrition 0.000 description 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 3
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- -1 synanthrin Polymers Chemical compound 0.000 description 3
- XXLFLUJXWKXUGS-UHFFFAOYSA-N 6-methoxyquinoline-4-carboxylic acid Chemical compound N1=CC=C(C(O)=O)C2=CC(OC)=CC=C21 XXLFLUJXWKXUGS-UHFFFAOYSA-N 0.000 description 2
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 102000040350 B family Human genes 0.000 description 2
- 108091072128 B family Proteins 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 239000002083 C09CA01 - Losartan Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 244000205754 Colocasia esculenta Species 0.000 description 2
- 235000006481 Colocasia esculenta Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000675 anti-caries Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 229940118199 levulan Drugs 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000010603 pastilles Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 2
- 229960002855 simvastatin Drugs 0.000 description 2
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000722910 Burkholderia mallei Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 101000937129 Drosophila melanogaster Cadherin-related tumor suppressor Proteins 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 229920000377 Sinistrin Polymers 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 108010090785 inulinase Proteins 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000004322 lipid homeostasis Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 229960004773 losartan Drugs 0.000 description 1
- KJJZZJSZUJXYEA-UHFFFAOYSA-N losartan Chemical compound CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2[N]N=NN=2)C=C1 KJJZZJSZUJXYEA-UHFFFAOYSA-N 0.000 description 1
- 229960000519 losartan potassium Drugs 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 201000008006 pharynx cancer Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
- 229950000329 thiouracil Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 150000003625 trehaloses Chemical class 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
Abstract
Description
成分 | 菊粉 | 蛋白质 | 脂肪 | 粗纤维 | 灰分 | 水分 |
含量(%) | 54.07 | 8.86 | 1.45 | 3.56 | 3.65 | 8.39 |
组别 | 大鼠(只) | 用药前(mmHg) | 用药后4周(mmHg) |
空白组 | 8 | 163.22 | 168.24 |
西药组 | 8 | 162.99 | 144.25 |
实施例1组 | 8 | 163.16 | 149.23 |
实施例2组 | 8 | 162.75 | 148.56 |
实施例3组 | 8 | 163.51 | 147.99 |
实施例4组 | 8 | 163.08 | 146.85 |
实施例5组 | 8 | 162.32 | 147.68 |
对比例组 | 8 | 163.02 | 154.23 |
组别 | 大鼠(只) | TC | TG |
高脂模型组 | 8 | 20.58 | 0.89 |
西药组 | 8 | 14.45 | 0.37 |
实施例1组 | 8 | 12.35 | 0.42 |
实施例2组 | 8 | 13.23 | 0.46 |
实施例3组 | 8 | 12.79 | 0.39 |
实施例4组 | 8 | 12.85 | 0.41 |
实施例5组 | 8 | 13.06 | 0.40 |
对比例组 | 8 | 16.72 | 0.62 |
组别 | 大鼠(只) | LDL-C | HDL-C |
高脂模型组 | 8 | 12.34 | 0.37 |
西药组 | 8 | 8.42 | 1.75 |
实施例1组 | 8 | 7.26 | 1.92 |
实施例2组 | 8 | 7.45 | 1.87 |
实施例3组 | 8 | 7.39 | 1.90 |
实施例4组 | 8 | 7.36 | 1.91 |
实施例5组 | 8 | 7.41 | 1.89 |
对比例组 | 8 | 9.33 | 1.02 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611123265.6A CN106615431B (zh) | 2016-12-08 | 2016-12-08 | 一种菊芋片茶及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611123265.6A CN106615431B (zh) | 2016-12-08 | 2016-12-08 | 一种菊芋片茶及其制作方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106615431A true CN106615431A (zh) | 2017-05-10 |
CN106615431B CN106615431B (zh) | 2020-11-13 |
Family
ID=58818837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611123265.6A Active CN106615431B (zh) | 2016-12-08 | 2016-12-08 | 一种菊芋片茶及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106615431B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107213261A (zh) * | 2017-06-12 | 2017-09-29 | 吴庆旺 | 有机硒组合物、其制备方法及其用途 |
CN107836545A (zh) * | 2017-11-08 | 2018-03-27 | 深圳瑞德源健康科技有限公司 | 一种菊芋叶养生袋泡茶及其制备方法 |
CN107836555A (zh) * | 2017-11-08 | 2018-03-27 | 深圳瑞德源健康科技有限公司 | 一种菊芋软糖及其制作方法 |
CN107836675A (zh) * | 2017-11-08 | 2018-03-27 | 深圳瑞德源健康科技有限公司 | 一种菊芋罐头及其制作方法 |
CN108669541A (zh) * | 2018-05-15 | 2018-10-19 | 吉林省白山本苜药业有限公司 | 具有抗癌、提高人体免疫力、延缓衰老、降三高功能的保健食品及其制备方法 |
WO2019090976A1 (zh) * | 2017-11-08 | 2019-05-16 | 深圳瑞德源健康科技有限公司 | 一种菊芋胶囊及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1435106A (zh) * | 2002-02-01 | 2003-08-13 | 大连绿山科技有限公司 | 菊芋茶包的制法 |
CN103168870A (zh) * | 2013-02-27 | 2013-06-26 | 河南科技大学 | 一种减肥保健茶及其制备方法 |
CN103222527A (zh) * | 2013-05-23 | 2013-07-31 | 徐州天马敬安食品有限公司 | 一种菊芋牛蒡茶的制作方法 |
CN104644759A (zh) * | 2013-11-22 | 2015-05-27 | 富力 | 一种预防或/和治疗流感的保健茶及其制备方法 |
-
2016
- 2016-12-08 CN CN201611123265.6A patent/CN106615431B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1435106A (zh) * | 2002-02-01 | 2003-08-13 | 大连绿山科技有限公司 | 菊芋茶包的制法 |
CN103168870A (zh) * | 2013-02-27 | 2013-06-26 | 河南科技大学 | 一种减肥保健茶及其制备方法 |
CN103222527A (zh) * | 2013-05-23 | 2013-07-31 | 徐州天马敬安食品有限公司 | 一种菊芋牛蒡茶的制作方法 |
CN104644759A (zh) * | 2013-11-22 | 2015-05-27 | 富力 | 一种预防或/和治疗流感的保健茶及其制备方法 |
Non-Patent Citations (2)
Title |
---|
康源春等: "《珍稀食用菌栽培技术》", 30 November 2008, 郑州:中原农民出版社 * |
杜同仿: "《中国中草药图典 下》", 31 January 2011, 广州:广东科技出版社 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107213261A (zh) * | 2017-06-12 | 2017-09-29 | 吴庆旺 | 有机硒组合物、其制备方法及其用途 |
CN107836545A (zh) * | 2017-11-08 | 2018-03-27 | 深圳瑞德源健康科技有限公司 | 一种菊芋叶养生袋泡茶及其制备方法 |
CN107836555A (zh) * | 2017-11-08 | 2018-03-27 | 深圳瑞德源健康科技有限公司 | 一种菊芋软糖及其制作方法 |
CN107836675A (zh) * | 2017-11-08 | 2018-03-27 | 深圳瑞德源健康科技有限公司 | 一种菊芋罐头及其制作方法 |
WO2019090976A1 (zh) * | 2017-11-08 | 2019-05-16 | 深圳瑞德源健康科技有限公司 | 一种菊芋胶囊及其制备方法 |
CN108669541A (zh) * | 2018-05-15 | 2018-10-19 | 吉林省白山本苜药业有限公司 | 具有抗癌、提高人体免疫力、延缓衰老、降三高功能的保健食品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106615431B (zh) | 2020-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104287013B (zh) | 一种降血脂降血糖功能性保健醋饮料及其生产工艺 | |
CN106615431A (zh) | 一种菊芋片茶及其制作方法 | |
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
CN102578646B (zh) | 一种保健饮料 | |
CN102827750A (zh) | 一种具有提高机体免疫力及性活力的玛咖保健酒 | |
CN103740566B (zh) | 一种刺梨药酒及其制作方法 | |
CN102965235B (zh) | 一种板栗养生酒 | |
CN102613330A (zh) | 发酵红曲茶及提取物、提取物组合物及其制备方法 | |
CN106360213A (zh) | 一种黄精植物饮料及其制备方法 | |
KR20150040392A (ko) | 스테비아 음료원액제조방법 | |
CN102613331B (zh) | 蜜环菌发酵茶、蜜环菌发酵茶组合物及其制备及方法 | |
CN107751993A (zh) | 一种抗疲劳膏滋及其制备方法 | |
CN102021101B (zh) | 可防治心脑血管疾病的益寿养生酒的制备方法 | |
CN110051815A (zh) | 一种辅助降血糖食丸及其制备方法 | |
KR20130137066A (ko) | 동아 막걸리 제조방법 | |
CN103055157B (zh) | 一种复方霍斛蓉芝颗粒及其生产工艺 | |
KR101716297B1 (ko) | 생약성분이 함유된 노루궁뎅이버섯 추출 음료 제조방법 및 그 방법으로 제조된 음료 | |
KR20060131374A (ko) | 강장 또는 강정용 한방주 및 이의 제조방법 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN104186657B (zh) | 一种白术奶醋绿茶保健饮料 | |
CN108220094A (zh) | 一种松露保健酒及其制备方法 | |
KR101647917B1 (ko) | 초석잠 추출물을 포함하는 약재 추출액과 밤 약술 및 그 제조방법 | |
CN103431100B (zh) | 一种具有保健养生作用的芦笋饮料 | |
CN110810693A (zh) | 一种含有显齿蛇葡萄的饮料组合物及其制备方法 | |
JPH0767576A (ja) | 菌糸体健康食材 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171215 Address after: 518000 room nine, room A, Four Points & Suites Calgary West Hotel, No. 5, No. 5, Guhua Road, Futian District Fubao Street free zone, Futian District Applicant after: SHENZHEN RUIDEYUAN HEALTH TECHNOLOGY Co.,Ltd. Address before: 256815 Shandong Province, Binzhou city Zhanhua District Li Guo Xiang Ma Ying Cun nine Applicant before: SHANDONG XINTANGYUAN AGRICULTURAL TECHNOLOGY CO.,LTD. |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20180206 Address after: 256815 Shandong city of Binzhou province Zhanhua Li Guo Xiang Ma Ying Cun nine Applicant after: SHANDONG XINTANGYUAN AGRICULTURAL TECHNOLOGY CO.,LTD. Address before: 518000 room nine, room A, Four Points & Suites Calgary West Hotel, No. 5, No. 5, Guhua Road, Futian District Fubao Street free zone, Futian District Applicant before: SHENZHEN RUIDEYUAN HEALTH TECHNOLOGY Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180928 Address after: 271000 1 South Lane Street, Da Wen Kong Industrial Park, man Zhuang Town, Daiyue District, Tai'an, Shandong Applicant after: SHANDONG ZHIYIYUAN HEALTH TECHNOLOGY Co.,Ltd. Address before: 256815 Ma Ying nine village, Li Guo Township, Zhanhua, Binzhou, Shandong Applicant before: SHANDONG XINTANGYUAN AGRICULTURAL TECHNOLOGY CO.,LTD. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 271024 No.1 Nanliu street, Dawenkou Industrial Park, manzhuang Town, Daiyue district, Tai'an City, Shandong Province Patentee after: Shandong yidelai Biotechnology Co.,Ltd. Address before: 271000 1 South Lane Street, Da Wen Kong Industrial Park, man Zhuang Town, Daiyue District, Tai'an, Shandong Patentee before: SHANDONG ZHIYIYUAN HEALTH TECHNOLOGY Co.,Ltd. |